Ferric carboxymaltose
- Generic Name
- Ferric carboxymaltose
- Brand Names
- Injectafer
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9007-72-1
- Unique Ingredient Identifier
- 6897GXD6OE
- Background
Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.
- Indication
Ferric carboxymaltose is an iron replacement product indicated for the treatment of iron deficiency anemia in patients ≥1 year of age who have an intolerance to, or unsatisfactory response from, oral iron therapy. It is also indicated in adult patients who have non-dialysis-dependent chronic kidney disease.
- Associated Conditions
- Iron Deficiency Anemia (IDA)
- Associated Therapies
- -
Comparing Intravenous and Oral Iron in Postoperative Anemia
- Conditions
- Interventions
- First Posted Date
- 2013-08-01
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Parc de Salut Mar
- Target Recruit Count
- 122
- Registration Number
- NCT01913808
- Locations
- 🇪🇸
Hospital de la Esperanza (Parc de Salut MAR), Barcelona, Spain
Iron in Congestive Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2013-04-22
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- University of Ulm
- Target Recruit Count
- 18
- Registration Number
- NCT01837082
- Locations
- 🇩🇪
University of Ulm, Ulm, Germany
🇩🇪University of Aachen, Aachen, Germany
🇩🇪University Heart Center Hamburg, Hamburg, Germany
Intravenous High Dose Iron in Blood Donors
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2016-10-06
- Lead Sponsor
- Medical University of Graz
- Target Recruit Count
- 176
- Registration Number
- NCT01787526
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia
- Conditions
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- Nottingham University Hospitals NHS Trust
- Target Recruit Count
- 116
- Registration Number
- NCT01701310
- Locations
- 🇬🇧
University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, West Midlands, United Kingdom
🇬🇧St James University Hospitals NHS Trust, Leeds, United Kingdom
Preoperative Intravenous Iron to Treat Anaemia in Major Surgery
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 487
- Registration Number
- NCT01692418
- Locations
- 🇬🇧
University College London, London, United Kingdom
🇬🇧Broomfield Hospital, Broomfield, United Kingdom
🇬🇧Queen Elizabeth Hospital, Gateshead, United Kingdom
Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
- Conditions
- Interventions
- First Posted Date
- 2012-01-20
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- GWT-TUD GmbH
- Target Recruit Count
- 152
- Registration Number
- NCT01513369
- Locations
- 🇩🇪
Gemeinschaftspraxis Dres. Grüneberg, Mehring, Stude, Herne, Nordrhein-Westfalen, Germany
🇩🇪Univesitätsklinikum Carl Gustav Carus, Dresden, Sachsen, Germany
🇩🇪Studienzentrum Professor Hanefeld Abakus Büropark, Dresden, Germany
Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
- Conditions
- Interventions
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 15
- Registration Number
- NCT01245777
- Locations
- 🇨🇭
University Hospital Zurich, Neurology, Zurich, Switzerland
🇨🇭Neurocenter of Southern Switzerland, Ospedale Civico, Lugano, Ticino, Switzerland
Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2015-07-28
- Target Recruit Count
- 303
- Registration Number
- NCT01154491
- Locations
- 🇪🇸
Hospital de la Vega Baja, Orihuela, Alicante, Spain
🇪🇸Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
- First Posted Date
- 2010-04-09
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Vifor Pharma
- Target Recruit Count
- 19
- Registration Number
- NCT01101399
- Locations
- 🇸🇪
Department of Medicine, St Görans Hospital (Capio St Görans Sjukhus), Stockholm, Sweden
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
- First Posted Date
- 2010-04-09
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Vifor Pharma
- Target Recruit Count
- 3
- Registration Number
- NCT01100879
- Locations
- 🇫🇷
Hopital Sud, Rennes, France
🇬🇷Theagenion Cancer Center, Thessaloniki, Greece
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.